T 0023/22 (Low N-glycolylneuraminic acid/LEK) of 14.06.2024
- European Case Law Identifier
- ECLI:EP:BA:2024:T002322.20240614
- Date of decision
- 14 June 2024
- Case number
- T 0023/22
- Petition for review of
- -
- Application number
- 10781888.2
- IPC class
- C12N 5/00C07K 14/47C12P 21/00
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Production of glycoproteins with low N-glycolylneuraminic acid (Neu5Gc) content
- Applicant name
- LEK Pharmaceuticals d.d.
- Opponent name
- Maiwald GmbH
- Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 54European Patent Convention Art 56European Patent Convention Art 83
- Keywords
- Main request - Novelty - (no)
Auxiliary request 1 - Inventive step (yes) - non-obvious alternative - Sufficiency of disclosure (yes) - Catchword
- -
- Citing cases
- T 1913/21
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the opposition division with the order to maintain the patent in amended form with the following set of claims, and a description and drawings adapted thereto as necessary:
claims 1 to 12 of auxiliary request 1 filed with the reply to the statement of grounds of appeal.